Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Onconova Therapeutics

NASDAQ ONTX
$7.93 6.93 87.45%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

174.63M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-3.37T
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.82
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
22.02M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
963.57 %

Upcoming events Onconova Therapeutics

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Onconova Therapeutics

Stock analysis Onconova Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-10.06 -458.16
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
16.36 4,242.37
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
181,384.65 -447.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
181,394.04 0.61
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-162.64 -9.36

Price change Onconova Therapeutics per year

3.47$ 28.05$
Min Max

Summary analysis Onconova Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Onconova Therapeutics

Revenue and net income Onconova Therapeutics

All parameters

Stock news Onconova Therapeutics

All news
12 October 2023 в 21:30

Onconova Therapeutics Shares Rise 12% On Skin Cancer Treatment Data

12 October 2023 в 21:30

Onconova Therapeutics Shares Rise 12% On Skin Cancer Treatment Data

7 February 2023 в 16:25

Onconova Therapeutics Gets Positive Data for Rigosertib Trial Participant

7 February 2023 в 16:25

Onconova Therapeutics Gets Positive Data for Rigosertib Trial Participant

24 September 2021 в 21:25

Onconova Therapeutics Shares Lower After Offering Prices at $4.20/Shr

24 September 2021 в 21:20

Onconova Therapeutics Shares Lower After Offering Prices at $4.20/Shr

24 September 2021 в 15:30

Onconova Therapeutics Offering Prices at $4.20/Shr

24 September 2021 в 15:30

Onconova Therapeutics Offering Prices at $4.20/Shr

24 September 2021 в 13:40

Onconova Therapeutics to Sell Shares in Public Offering

24 September 2021 в 13:40

Onconova Therapeutics to Sell Shares in Public Offering

22 September 2021 в 15:35

Onconova Therapeutics Shares Jump After Lung-Cancer-Trial Data

22 September 2021 в 15:30

Onconova Therapeutics Shares Jump After Lung-Cancer-Trial Data

21 November 2019 в 16:27

Лидеры и аутсайдеры Уолл-cтрит: Hepion Pharmaceuticals, TD Ameritrade Holding, Onconova Therapeutics

About company Onconova Therapeutics

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON 123300 to target CDK4/6 and other tyrosine kinases. The company's product candidate oral rigosertib, which is in Phase 1 study of rigosertib in combination with a PD-1 inhibitor for patients with progressive K-Ras mutated non-small cell lung cancer; and in Phase 1b/2 for recessive dystrophic epidermolysis bullosa. In addition, it is involved in preclinical work investigating rigosertib in COVID-19. The company has a license agreement with SymBio Pharmaceuticals Limited; and license, development, and commercialization agreement with Pint International SA. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.
Address:
375 Pheasant Run, Newtown, PA, United States, 18940
Company name: Onconova Therapeutics
Issuer ticker: ONTX
ISIN: US68232V8019
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2013-07-25
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.onconova.com

On which stock exchange are Onconova Therapeutics (ONTX) stocks traded?

Onconova Therapeutics (ONTX) stocks are traded on NASDAQ.

What is the ticker of Onconova Therapeutics stocks (ONTX)?

The stock ticker of Onconova Therapeutics’s stocks or in other words, the code is ONTX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Onconova Therapeutics (ONTX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Onconova Therapeutics (ONTX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Onconova Therapeutics (ONTX) stocks traded?

Onconova Therapeutics (ONTX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Onconova Therapeutics (ONTX) stocks today?

The current price of Onconova Therapeutics stocks on 11.05.2024 is 7.93 dollars. per share.

What is the dynamics of Onconova Therapeutics (ONTX) stocks from the beginning of the year?

Onconova Therapeutics (ONTX) quotes have increased by 903.8% from the beginning of the year up to 7.93 dollars. per 1 stocks.

How much did Onconova Therapeutics (ONTX) stocks increase in мае 2024?

This month Onconova Therapeutics (ONTX) quotes have increased by 0% to 7.93 dollars. per share.

How much are Onconova Therapeutics (ONTX) stocks worth?

Today, on October, 11.05.2024 Onconova Therapeutics’s (ONTX) stocks cost 7.93 dollars..

What is the market capitalization of Onconova Therapeutics (ONTX)?

Capitalization is the market value of Onconova Therapeutics (ONTX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 11.05.2024, the market capitalization of Onconova Therapeutics (ONTX) is estimated at about 174627323 dollars.